4.8 Article

Sustained local delivery of siRNA from an injectable scaffold

Journal

BIOMATERIALS
Volume 33, Issue 4, Pages 1154-1161

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2011.10.033

Keywords

RNA interference; Drug delivery; RAFT; Tissue engineering; Polyurethane; Controlled release

Funding

  1. NIH [CA68485, DK20593, DK58404, HD15052, DK59637, Ey008126, R21EB012750, 1R01AR056138-01A2]
  2. Vanderbilt Discovery Grant

Ask authors/readers for more resources

Controlled gene silencing technologies have significant, unrealized potential for use in tissue regeneration applications. The design described herein provides a means to package and protect siRNA within pH-responsive, endosomolytic micellar nanoparticles (si-NPs) that can be incorporated into nontoxic, biodegradable, and injectable polyurethane (PUR) tissue scaffolds. The si-NPs were homogeneously incorporated throughout the porous PUR scaffolds, and they were shown to be released via a diffusion-based mechanism for over three weeks. The siRNA-loaded micelles were larger but retained nanoparticulate morphology of approximately 100 nm diameter following incorporation into and release from the scaffolds. PUR scaffold releasate collected in vitro in PBS at 37 degrees C for 1-4 days was able to achieve dose-dependent siRNA-mediated silencing with approximately 50% silencing achieved of the model gene GAPDH in NIH3T3 mouse fibroblasts. This promising platform technology provides both a research tool capable of probing the effects of local gene silencing and a potentially high-impact therapeutic approach for sustained, local silencing of deleterious genes within tissue defects. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available